1,3-dihydro-5-isobenzofurancarbonitrile derivatives and pharmaceutical composition thereof for the treatment of premature ejaculation
申请人:Dong-A Pharmaceutical. Co., Ltd
公开号:US08242159B2
公开(公告)日:2012-08-14
Disclosed herein are novel 1,3-dihydro-5-isobenzofurancarbonitrile derivatives represented by Formula 1, or pharmaceutically acceptable salts thereof. Also disclosed is a pharmaceutical composition for treating or preventing premature ejaculation including the compound. The 1,3-dihydro-5-isobenzofurancarbonitrile derivatives have a short half-life and inhibit the ejaculation process by selectively inhibiting serotonin reuptake via a serotonin reuptake transporter present in a presynaptic neuron. Thus, the compounds are useful in the treatment and prevention of premature ejaculation.
本文揭示了一种由式1所代表的新型1,3-二氢-5-异苯并呋喃-碳腈衍生物,或其药学上可接受的盐。同时还揭示了一种用于治疗或预防早泄的药物组合物,包括该化合物。这些1,3-二氢-5-异苯并呋喃-碳腈衍生物具有短的半衰期,并通过选择性抑制存在于突触前神经元中的5-羟色胺再摄取转运体,从而抑制射精过程。因此,这些化合物在早泄的治疗和预防中是有用的。